Delivery Order SPE2DR25D1017-SPE2DR26F8ZJS
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,032.11 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 2, 2025, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of May 12, 2025, and utilizes no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,321.10 on September 22, 2025, for the supply of Varivax vaccine with diluents to support federal medical procurement needs. This firm fixed price contract, which is expected to be completed by October 14, 2025, represents a non-competitive award issued by the Defense Logistics Agency's Medical Supply Chain division. The contract will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $1,998.92. This firm fixed price, competitively awarded contract was issued on November 4, 2025, with an ultimate completion date of November 26, 2025. The deliverables will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on November 7, 2025, with a ceiling value of $1,998.92 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Varivax vaccine with diluents valued at $10,321.10 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The contract is set to complete by July 22, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Varivax vaccine with diluents, valued at $2,064.22. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) for the supply of Varivax vaccine with diluents. The award, issued on July 7, 2025, with an ultimate completion date of July 28, 2025, carries a firm fixed price structure and represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,096.33 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. This competitive award, issued on September 4, 2025, carries a firm fixed price and is scheduled for ultimate completion by September 25, 2025. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZJSDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,998.92 by the Defense Logistics Agency on November 10, 2025, for the supply of Varivax vaccine with diluents. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. As a child contract, this delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal vendor specializing in medical product procurement for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents a routine execution of the company's prime vendor responsibilities under the DLA's global pharmaceutical support framework, enabling timely vaccine distribution to support military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/10/25 |